Literature DB >> 7718254

The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma.

R G Steinbeck1, K M Heselmeyer, H B Moberger, G U Auer.   

Abstract

Proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 overexpression were studied by means of image cytometry and immunohistochemistry respectively in normal mucosa (n = 10), in mild (n = 16), moderate (n = 9) and severe (n = 17) atypical lesions, as well as in squamous cell carcinomas (n = 36) of the cervix uteri. The results show that increasing histopathological atypia in the cervical mucosa was correlated to an initial increase of PCNA followed by distinct aneuploidy and p53 overexpression. The data are suggested to contribute to a better understanding of the genesis of cervical carcinoma, and to indicate that the coexistence of both distinct aneuploidy and p53 immunoreactivity can be used to decide if a cell population is neoplastic, whereas the absence of p53 overexpression does not necessarily exclude neoplasia. This diagnostic procedure can be suggested to improve early detection of intraepithelial squamous neoplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718254     DOI: 10.3109/02841869509093952

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  Proliferation in the normal cervix and in preinvasive cervical lesions.

Authors:  M K Heatley
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

Authors:  K Heselmeyer; E Schröck; S du Manoir; H Blegen; K Shah; R Steinbeck; G Auer; T Ried
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

3.  PCNA in Cervical Intraepithelial Neoplasia and Cervical Cancer: An Interaction Network Analysis of Differentially Expressed Genes.

Authors:  Panagiotis Giannos; Konstantinos S Kechagias; Sarah Bowden; Neha Tabassum; Maria Paraskevaidi; Maria Kyrgiou
Journal:  Front Oncol       Date:  2021-11-26       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.